Laila Mahmoudi
Co-Fondatrice
P
PhantasiAI
This medical technology company develops AI-powered, non-invasive electrical stimulation devices for neurological rehabilitation. Their platform tailors rehabilitation sessions to individual patient needs, optimizing recovery from neurological injuries and improving motor function.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Medical Devices
- Software Only
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Neuromuscular disorders resulting from stroke, spinal cord injury, cerebral palsy, and other neurological lesions inflict disabilities on millions, creating immense human and economic burden. Current rehabilitation methods often employ generic therapy sessions that fail to address individual patient needs, leading to long, exhausting, and expensive recovery processes.
Solution
PhantasiAI develops AI-powered neurotechnology to accelerate motor recovery and enhance muscular control after neural injuries. Their core product, VIDA, is a portable, user-friendly device designed to make rehabilitation affordable and accessible at home, ensuring a seamless transition from the clinic. VIDA leverages an AI algorithm to predict individual recovery paths and personalize therapy through adaptive neurostimulation, enhancing movement, improving independence, and improving quality of life.
Target Audience
The primary target audience includes individuals recovering from stroke, spinal cord injury, cerebral palsy, multiple sclerosis, amputation, and sports injuries, as well as the clinicians and therapists who support them.
Features
- Portable, user-friendly design for in-clinic and at-home rehabilitation
- AI-driven algorithm to predict individual recovery trajectories
- Personalized therapy through adaptive neurostimulation
- Technology applicable to a wide range of neuromuscular disorders, including stroke, spinal cord injury, and cerebral palsy